Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Pulse Biosciences Inc is a medical therapy company that pursues the commercial introduction of its proprietary CellFX System utilizing its patent-protected Nano-Pulse Stimulation (NPS) platform technology. Through its proprietary CellFX System, the company can deliver a cell-focused effect on dysfun... Pulse Biosciences Inc is a medical therapy company that pursues the commercial introduction of its proprietary CellFX System utilizing its patent-protected Nano-Pulse Stimulation (NPS) platform technology. Through its proprietary CellFX System, the company can deliver a cell-focused effect on dysfunctional cells while preserving surrounding non-cellular tissue, a combination that may potentially lead to both improved efficacy and less collateral tissue damage. Substantial revenue is generated from North America Majorly due to the sale of systems. Mehr anzeigen
Nanosecond PFA 360° Cardiac Catheter for AF ablation to be highlighted in late-breaking clinical science session and in a live case transmission Pulse Biosciences, Inc. (Nasdaq: PLSE), a company...
Current Co-Chairman of the Board will now also serve as Chief Executive Officer Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a company leveraging its novel and...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced plans to present at the...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced that it intends to...
Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™...
Preclinical data demonstrates advantages of the nano-PFA Cardiac Surgical System over radio frequency technology for ablation of cardiac tissue Pulse Biosciences, Inc. (Nasdaq: PLSE), a company...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.19 | -6.21734587252 | 19.14 | 19.27 | 17.49 | 112766 | 18.35119121 | CS |
| 4 | -1.56 | -7.9958995387 | 19.51 | 20.69 | 16.97 | 142483 | 18.19595508 | CS |
| 12 | 0.26 | 1.46975692482 | 17.69 | 21.8 | 14.06 | 173739 | 17.93661804 | CS |
| 26 | -0.06 | -0.333148250972 | 18.01 | 22.69 | 13.5 | 172282 | 17.73785 | CS |
| 52 | 10.04 | 126.927939317 | 7.91 | 22.69 | 6.595 | 192549 | 13.78555552 | CS |
| 156 | 5.45 | 43.6 | 12.5 | 22.69 | 1.18 | 183730 | 8.14690939 | CS |
| 260 | 2.88 | 19.1108161911 | 15.07 | 45.82 | 1.18 | 149716 | 10.66397759 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
